SCHEMBL71031

SCHEMBL71031

Nc1ccc(-c2ccccn2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.56
LMNA P02545 3/20 0.56
CYP1A2 P05177 2/20 0.56
CCR1 P32246 2/20 0.56
CCR5 P51681 2/20 0.56
CCR8 P51685 2/20 0.56
POLB P06746 1/20 0.56
METAP1 P53582 1/20 0.56
BLM P54132 1/20 0.56
HIF1A Q16665 1/20 0.56
DOHH Q9BU89 1/20 0.56
P4HTM Q9NXG6 1/20 0.56
TDP1 Q9NUW8 3/20 0.54
ALOX15 P16050 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
CYP2A6 P11509 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP19A1 P11511 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18555517 0.98 KDM4E (0.54) KDM4ELMNACYP1A2CCR1CCR5
SCHEMBL18745786 0.98 KDM4E (0.54) KDM4ELMNACYP1A2CCR1CCR5
Hydrochloric Acid SCHEMBL29687884 0.98 KDM4E (0.54) KDM4ELMNACYP1A2CCR1CCR5
Hydrochloric Acid SCHEMBL7130341 0.98 KDM4E (0.54) KDM4ELMNACYP1A2CCR1CCR5
Hydrochloric Acid SCHEMBL7130326 0.96 KDM4E (0.52) KDM4ELMNACYP1A2CCR1CCR5
SCHEMBL18745762 0.90 CYP2A6 (0.52) KDM4ELMNACYP1A2CCR1CCR5
SCHEMBL18745704 0.89 ASIC3 (0.55) KDM4ELMNACYP1A2CCR1CCR5
SCHEMBL28414628 0.89 MEN1 (0.56) KDM4ELMNACYP1A2CCR1CCR5
SCHEMBL11421934 0.89 CYP1A2 (0.53) KDM4ELMNACYP1A2CCR1CCR5
SCHEMBL30989133 0.88 KDM4E (0.72) KDM4ELMNACYP1A2CCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117659325-B Preparation method of covalent organic framework material with electrochemical activity 德州学院 2024-04-12 CN claimed
CN-114761452-B Method for preparing hollow covalent organic framework material 浙江大学 2024-04-09 CN claimed
CN-117844221-A Humidity-responsive PC/ABS composite material and preparation method and application thereof 江苏金发科技新材料有限公司 2024-04-09 CN claimed
CN-117753387-A Covalent organic framework nanocapsule material and emulsion acceleration polymerization method thereof 浙江大学 2024-03-26 CN claimed
CN-117659325-A Preparation method of covalent organic framework material with electrochemical activity 德州学院 2024-03-08 CN claimed
CN-113861419-B Preparation method of hyperbranched polyimide and perylene imide copolymer 株洲时代新材料科技股份有限公司 2023-10-20 CN claimed
CN-116813912-A Benzoxazinyl hyperbranched organic silicon resin and preparation method thereof 南京大学 2023-09-29 CN claimed
CN-116751399-A Amino hyperbranched siloxane modified polyimide foam material and preparation method thereof 南京大学 2023-09-15 CN claimed
CN-116355614-A Etching composition 安集微电子科技(上海)股份有限公司 2023-06-30 CN claimed
CN-116253882-A Preparation method of amino hyperbranched siloxane and modified polyimide aerogel material thereof 南京大学 2023-06-13 CN claimed
CN-107417734-B A kind of platinum complex and its preparation method and application with two-Photon Absorption Properties 中山大学 2019-08-20 CN claimed
CN-109134351-A S-3-(4- aminophenyl) piperidines synthetic method 武汉理工大学 2019-01-04 CN claimed
CN-103305961-A Production method of polyimide and carbon nanotube composite fibers CHANGCHUN APPLIED CHEMISTRY 2013-09-18 CN claimed
CN-102838745-A Preparation method of polyimide foam CHANGCHUN APPLIED CHEMISTRY 2012-12-26 CN claimed
US-20080207694-A1 Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them ROSSI CRISTINA 2008-08-28 US claimed
EP-1868997-A1 HYDROXAMATES AS HISTONE DEACETYLASE INHIBITORS AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM Menarini International Operations Luxembourg S.A. (LU) 2007-12-26 EP claimed
WO-2006097460-A1 HYDROXAMATES AS HISTONE DEACETYLASE INHIBITORS AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. (LU) 2006-09-21 WO claimed
CN-1733736-A Nitrogenous fragrant heterocyclic diamine and preparation method thereof CHANGCHUN APPLIED CHEMISTRY (CN) 2006-02-15 CN claimed
EP-0998472-A1 SUBSTITUTED 2-(BENZOARYL)PYRIDINES BASF AKTIENGESELLSCHAFT (DE) 2000-05-10 EP claimed
WO-1999006394-A1 SUBSTITUTED 2-(BENZOARYL)PYRIDINES BASF AKTIENGESELLSCHAFT (DE) 1999-02-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207694-A1 Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them HDAC1, HDAC8, HDAC9 KDM4E 183/4885LMNA 1681/4885CYP1A2 2700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.